tafamidis meglumine
pfizer
['pfizer']
#acc2023 begins today! pfizer is excited to share our research and commitment to the #attrcm community. #pfizermedical #amyloidosis 
Communicating emerging, trusted scientific information to healthcare professionals (HCPs). Pfizer sponsored, intended for U.S. HCPs. https://t.co/s5bPfuTvDc